Purpose: To assess the radiation dose reduction capabilities and the image quality of a new C-arm system in comparison to a standard C-arm system.
Method: Prospective, randomized, IRB approved two-arm trial design. 49 consecutive patients with primary or secondary liver cancer were treated with transarterial chemoembolization (TACE) on two different angiography units.